What is Docquity?
Docquity operates as a specialized continual learning network tailored for the medical community. By providing a secure, gated environment, the platform enables doctors to engage in clinical discussions, access interactive educational content, and earn essential CME/CPD credits. Its market position is defined by its focus on professional verification, ensuring that the exchange of clinical insights remains high-quality and compliant with privacy standards. As a digital bridge between medical experts and practitioners, Docquity is effectively digitizing the traditional medical conference and peer-review experience, thereby enhancing clinical outcomes through collaborative knowledge sharing.
How much funding has Docquity raised?
Docquity has raised a total of $55M across 2 funding rounds:
Series B
$11M
Series C
$44M
Series B (2019): $11M with participation from Itochu Corporation, Jo Hirao, KDV Holdings, and SPH Ventures
Series C (2022): $44M led by Alkemi, ITOCHU, Global Brain, Infocom, iGlobe Partners, and KDV
Key Investors in Docquity
ITOCHU
ITOCHU is one of the leading Japanese trading corporations. ITOCHU engages in domestic trading, import/export, and overseas trading of various products such as textile, machinery, metals, minerals, energy, chemicals, food, information and communications technology, realty, general products, insurance, logistics services, construction, and finance, as well as business investment in Japan and overseas.
Global Brain
Global Brain is an independent venture capital firm that specializes in supporting startups to achieve global success through hands-on assistance and collaboration with large corporations. With over $2.3 billion in assets under management, the firm actively invests in more than 100 startups annually, focusing on various sectors including technology, healthcare, and education.
iGlobe Partners
iGlobe Partners is a venture capital firm based in Singapore that specializes in identifying, investing in, and nurturing startups to become global leaders. Established in 1999, the firm has a strong track record with over 100 investments and has raised approximately US$400 million across five funds.
What's next for Docquity?
With the recent strategic investment, Docquity is poised to accelerate its regional expansion and deepen its technological capabilities. The company is expected to leverage this capital to enhance its webinar infrastructure, integrate advanced clinical decision-support tools, and potentially broaden its service offerings to include more comprehensive data analytics for healthcare institutions. As the platform continues to scale, the focus will likely shift toward deepening engagement with pharmaceutical partners and medical associations, further cementing its role as the primary digital ecosystem for healthcare professionals in Southeast Asia. The strategic backing from major corporate and venture entities provides not only the necessary liquidity but also the operational expertise required to navigate the complexities of the regional healthcare sector.
See full Docquity company page
